Cancer, Breast
Prognostic value of PAM50 and risk of recurrence score in patients with early stage breast cancer with long term follow up
... early-stage breast cancer with 17 years follow-up, the PAM50 subtypes and ROR scores clearly improved the prognostic classification beyond current clinicopathological ...and breast ...
12
The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity: A case-control study
... increase breast cancer risk and taxane- related sensory neuropathy in the PGSNPS ...of breast cancer risk alleles and decreased risk of experiencing chemotherapy-induced neutropenia grade 3 ...
13
Alexithymia and Breast Cancer Surgery: A Systematic Review
... The term alexithymia is a complex multidimensional construct that literally means “no words for mood”. There are two kind of alexithymia: primary and secondary or otherwise called trait and state alexithymia. There is ...
11
Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer
... Background: Breast cancer (BC) is a genetic disorder characterized by growth and proliferation of breast cells in a disorderly. In Brazil, there are approximately 49.240 new cases of BC, every year. ...
6
Combining quantitative and qualitative breast density measures to assess breast cancer risk
... prospective breast imaging ...Vermont Breast Cancer Surveillance System (VBCSS) participate in the National Cancer Institute- funded BCSC ...
9
Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients
... of breast cancer patients, we examined NOS2 expression and its association with tumor markers and survival in 248 breast ...basal-like breast cancer with poor ...ER-negative ...
13
The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population: a case control study
... with breast cancer at the age of less than 40 years and among subjects with a family history of breast cancer (defined as an individual with two or more cases of breast cancer in ...
5
TSH receptor antibodies have predictive value for breast cancer – retrospective analysis
... of breast cancer in previous reports and in our ...of breast cancer on the thyroid with the resulting increased level of thyroid hor- mones and the autoimmune response with the detect- able ...
8
Online Diagnostic Expert System for Detection of Breast Cancer in Saudi Arabia
... Breast cancer has plenty of myths and facts surrounding its causes and risk factors. Although the exact cause has not been identified, several risk factors have been determined for this disease. Age, ...
8
Mammographic breast density refines Tyrer Cuzick estimates of breast cancer risk in high risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I
... for breast cancer, however, adjustment for age and body mass index (BMI) is vital to its clinical interpretation when assessing individual ...and breast cancer risk in a nested case-control ...
6
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
... No cytotoxic or molecularly targeted agent is approved for the treatment or prevention of BCBM [11, 12]. Molecular weight, lipophilicity, biodistribution, and drug efflux pumps all contribute to poor penetration of drugs ...
13
Breast Cancer Diagnosis by CAD
... damage. Breast cancer is a malignant tissue beginning to grow in the ...a breast mass change in shape and dimension of breast, differences in the color of breast skin, breast ...
5
Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway
... in cancer cells in melanoma, glioma, and prostate cancer [16, ...regulate breast cancer progression and metastasis [24, ...of breast cancer development remains to be ...on ...
16
Abstract: Breast cancer is the most common cancer in women and distant site metastasis is the
... in breast cancer resistance to chemotherapy and/or target therapies has been ...from breast cancer patients treated with neoadjuvant therapy ...primary breast cancer patients by ...
18
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
... Australian Breast Cancer Family Study; ABCS, Amsterdam Breast Cancer Study; BBCC, Bavarian Breast Cancer Cases and Controls; BBCS, British Breast Cancer Study; ...
25
Genetic risk variants associated with in situ breast cancer
... BC: breast cancer; BCAC: Breast Cancer Association Consortium; BCIS: breast cancer in situ; BMI: body mass index; BPC3: National Cancer Institute ’ s Breast and ...
10
Breast Cancer- In 21st Century Current Status and Future Perspective
... for breast cancer include: Cisplatin (Platinol) Cyclophosphamide (Neosar) Docetaxel (Docefrez, Taxotere) Doxorubicin (Adriamycin) Epirubicin (Ellence) Eribulin (Halaven) Fluorouracil (5-FU, Adrucil) ...
6
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer
... The low prevalence of IBC, and the small size of diag- nostic biopsy specimens have been obstacles in under- standing of IBC pathogenesis. To date, current treatments are based on multimodal approaches, are non-specific ...
13
Original Article The correlation of PTPN4 expression with prognosis in breast cancer
... of breast cancer’s molecular subtypes, has improved the dis- ease’s ...for breast cancer ...in breast cancer, and the potential role of PTPN4 in the prognosis of breast ...
9
Original Article Bmi-1 regulates epithelial-to-mesenchymal transition to promote migration and invasion of breast cancer cells
... in breast cancer cells, especially over- expressed in metastatic cancer cells (Figure ...human breast cancer and metastatic breast cancer ...in breast cancer ...
8